Mitochondrial dysfunction and reactive oxygen species (ROS) are often implicated in diseases involving oxidative stress and elevated iron. As mitochondria produce ATP by oxidative phosphorylation, ROS by-products are generated from the electron transport chain. Although superoxide and hydrogen peroxide have been thoroughly investigated, little evidence documents hydroxyl radical (HO -scavenger studies support a Fenton-type reaction mechanism. The results indicate that increased HO
) production in mitochondria. In order to determine whether HO • • is generated under oxidative stress conditions by a Fenton-type mechanism, bovine heart submitochondrial particles were examined for HO -scavenger studies support a Fenton-type reaction mechanism. The results indicate that increased HO
• • levels occur in mitochondria under oxidative stress and that the HO • • levels can be modulated with antioxidant enzymes and iron ligands. Our findings together with reports on iron accumulation in degenerative diseases highlight the importance of developing mitochondrial-targeted antioxidants for the therapeutic intervention of diseases associated with mitochondrial dysfunction and oxidative stress.
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Introduction
Energy demands of complex aerobic organisms require the efficient synthesis of ATP by mitochondrial oxidative phosphorylation. In conjunction with ATP synthesis, however, aerobic organisms are exposed to reactive oxygen species (ROS) that are byproducts of the mitochondrial electron transport chain. Under conditions of persistent oxidant production, such as during mitochondrial electron transport chain dysfunction, antioxidant enzymes that remove ROS may be overwhelmed causing oxidative stress. Oxidative stress has been implicated in the pathology of degenerative diseases, including carcinogenesis, hemochromatosis, Parkinson's disease, Vol 14 No 3 103
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Alzheimer's disease, Friedreich's ataxia and aging itself. [1] [2] [3] [4] [5] [6] Diseases associated with tissue iron accumulation are of particular concern, 7-10 as iron catalyzes the generation of the highly reactive ROS, hydroxyl radical (HO • ). During oxidative stress, mitochondria may be important sites for sustained HO
• production via the Fenton reaction as the precursors and catalysts for Fenton chemistry are co-located within the mitochondrial matrix. Superoxide anion radical is produced in the matrix at complexes I 11 and III 12 of the electron transport chain. Hydrogen peroxide is formed from superoxide by Mn-containing superoxide dismutase. Low molecular weight iron is present 13 and iron ligands that permit iron redox-cycling are abundant.
14 Thus, an HO • flux could be generated in mitochondria by the Fenton reaction (Eq. 1), driven by the reduction of iron by superoxide (Eq. 2) in the presence of an iron catalyst which is chelated to a ligand that facilitates redox cycling. Under mitochondrial oxidative stress conditions which favor Fenton chemistry and iron reduction by superoxide, HO
• could cause significant biological damage. The purpose of this study was to test the hypothesis that HO
• is produced via the Fenton reaction in mitochondria under oxidative stress and that mitochondrial HO
• production can be modulated by manipulating Fenton reaction conditions.
Materials and methods

Chemicals
All reagents were of the highest grade possible from Sigma-Aldrich Chemical Co. (St Louis, MO, USA), EM Science or JT Baker (VWR, West Chester, PA, USA) and were used as received from the supplier. The HPLC standards, 2,3-and 2,5-dihydroxybenzoic acid, were purchased from Sigma-Aldrich Chemical Co.
HPLC hydroxyl radical assay
Hydroxyl radical was measured by aromatic hydroxylation using salicylate (2-hydroxybenzoate) as a trap according to published methods. 15 The analytes, 2,3-and 2,5-dihydroxybenzoic acid (DHBA), were detected using a high-performance liquid chromatograph (HPLC) equipped with a DHBA-250 column (5 µm particle size; 250 mm × 3 mm i.d. column size) and a Coularray electrochemical detector from ESA, Inc.
(Chelmsford, MA, USA). The elution profile was linear with a mobile phase of 50 mM sodium acetate, 50 mM citric acid, 25% methanol (v/v), and 5% 2-propanol (v/v), adjusted to pH 2.5 with phosphoric acid. The mobile phase was prepared in 18.3 MΩ-cm resistance ultrapure water from a NANOpure system (Barnstead, Dubuque, IA, USA), and was further purified by a C 18 cartridge (Waters, Milford, MA, USA) to remove trace organics. The DHBA-250 column temperature was maintained at 27ºC and the flow rate at 0.5 ml/min throughout the analysis. DHBA concentrations were calculated by reference to 2,3-and 2,5-DHBA standard curves that were linear with correlation coefficients of r 2 ≥ 0.98.
Isolation of mitochondria and submitochondrial particles
Bovine heart submitochondrial particles (SMPs) were prepared by differential centrifugation and sonication according to published methods, 16 except that no EDTA was added. The sonication of mitochondrial solutions inverts the inner mitochondrial membrane to form SMPs. This inversion permits the facile analysis of chemical reactions that occur on the matrix face of the inner mitochondrial membrane. The SMPs were uncoupled by several freeze-thaw cycles until additions of ADP in the presence of electron transport chain substrates did not increase oxygen consumption rates. The SMPs were also exhaustively washed to remove matrix components such as mitochondrial DNA and enzymes. All isolation buffers and solutions were treated with Chelex-100 mesh resin (BioRad) to remove trace metals. SMP protein concentrations were determined by the Biuret method with bovine serum albumin as the standard.
Succinate oxidase (EC 1.3.5.1) enzyme assay
Before SMPs were used for experiments, electron transport chain function was assessed with succinate oxidase activity which tests electron flow through complexes II, III, and IV, coenzyme Q, and cytochrome c. Succinate is oxidized by complex II and donates electrons via the electron transport chain to complex IV where oxygen is reduced to water and removed from solution. Thus, succinate oxidase enzyme activity was monitored by measuring rates of oxygen consumption with a Clarke electrode using 1.0 mM succinate as substrate in a 10 mM or 50 mM potassium phosphate buffer pH 7.0 with 1.00 mg SMP protein/ml as previously described. 17 SMP succinate oxidase specific activities ranged between 70-100 nmol O 2 /min/mg protein. Vol 
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SMP metal analysis by ICP-MS
Metal element concentrations were determined using an X-Series ASX-510 Inductively-Coupled Plasma Mass Spectrometer (ICP-MS) from Thermo Scientific Corporation. External metal standards (5-1000 ppb) were measured in triplicate with percentage standard deviations ranging from 3-11% for Fe. Three SMP samples were separated into membrane and supernatant fractions by centrifugation at 105,000 g for 55 min. The fractions were digested with nitric acid at 115ºC for 20 min. Samples were diluted to a final concentration of 5% nitric acid before analysis in triplicate.
Submitochondrial particle incubation and Fenton chemistry reaction conditions
Submitochondrial particles were used in order to simplify measurement of hydroxyl radical formation on the matrix side of the inner mitochondrial membrane. ADP was used as a physiological iron chelator that occurs in the mitochondrial matrix. When electron transport is inhibited by antimycin A, superoxide levels are known to increase which induces an oxidative stress state. 18 Rotenone was used to stop reverse electron flow from complex II to complex I. The iron and ligand were first added to reaction tubes and the solution was thoroughly mixed by pipette. Following these two additions, buffer was introduced, then salicylate and any other components such as H 2 O 2 , mannitol and thiourea, SOD, or catalase. The reactant final concentrations were: 1.00 mg/ml, submitochondrial particle protein, 200 µM antimycin A, 2.5 µM rotenone, 10 mM or 75 mM sodium salicylate, 10 mM mannitol or thiourea, 50 U/ml SOD, 100 U/ml catalase and 1.0 mM disodium succinate in a 10 mM or 50 mM potassium phosphate buffer pH 7.0. Ligand effects were tested with 20 µM or 100 µM ADP and 100 µM desferrioxamine (DF) in the presence and absence of 1.0 µM or 2.0 µM FeCl 3 . Reactions were incubated at 30.0ºC for 0.5 h or 2.00 h, initiated with succinate and stopped with 0.40 M perchloric acid which precipitated mitochondrial protein. Each sample was centrifuged, filtered (0.22 µm, Corning spin-x), and the supernatants were analyzed for dihydroxybenzoic acids by HPLC with electrochemical detection.
Antioxidant enzyme studies: superoxide dismutase and catalase
Active superoxide dismutase (SOD) from bovine erythrocytes (Calbiochem, La Jolla, CA, USA) and catalase from bovine liver were used. Enzymes were inactivated by boiling for 1 h in capped microcentrifuge tubes. Using perchloric acid to precipitate proteins was found to decrease DHBA solubility and, therefore, was not used in the antioxidant enzyme studies. Instead, proteins were separated from supernatant by filtration. Specifically, after 0.5-h reaction time, 0.6 ml of each sample was filtered by centrifugation in a Spin-x microcentrifuge tube with a 0.22 µm nylon filter and supernatants were analyzed immediately by HPLC. Statistical analyses were performed using Student's t-test with the significance set at P < 0.05.
Statistical analysis
Results
In the presence of a physiological iron catalyst Fe(ADP), SMPs generated significantly more HO
• as total DHBA under oxidative stress conditions than under normal electron transport chain conditions (Fig. 1) . SMPs incubated without electron transport chain inhibitors produced only 4% of the HO proportion of SMP-generated HO
• was iron-ligand dependent, with Fe(desferrioxamine)-catalyzed HO
• levels significantly decreased as compared to Fe(ADP)-catalyzed levels (Fig. 2) . Given its log K (Table 1 ) and standard reduction potential values, 14 desferrioxamine is known to preferentially bind Fe 3+ and to inhibit its reduction by superoxide. 19 To test the hypothesis that HO
• production was dependent on superoxide and hydrogen peroxide, total DHBAs were measured in the presence and absence of exogenous SOD and catalase. The results clearly demonstrate that these antioxidant enzymes, when used individually and together, dramatically decrease DHBA production (Fig. 3) . To investigate this hypothesis further, exogenous H 2 O 2 was added to SMPs to examine its effects on Fenton reaction products. The results show that total DHBAs were elevated in parallel with increased exogenous H 2 O 2 (Table 2) . Interestingly, the results also show a trend towards increasing proportions of the 2,5-DHBA isomer and decreasing proportions of the 2,3-DHBA isomer in total DHBA values.
In order to test the hypothesis that a Fenton-type reaction occurred in SMPs, the effects of hydroxyl radical scavengers were investigated. Mannitol and thiourea, with second-order rate constants of 2. , respectively, were chosen. When equimolar concentrations (10 mM) of salicylate and scavenger were used, the total DHBA mean ± SD (n = 6) or propagated error (n = 2) observed were: salicylate alone, 159 ± 20 nM (n = 6); with mannitol, 91 ± 8 nM (n = 2); and with thiourea, 55 ± 3 nM (n = 2). All mean values were significantly different at P ≤ 0.05. The data demonstrate Endogenous iron concentrations appeared to contribute to the total DHBA generated in SMPs as shown in reactions in which ADP was added without FeCl 3 (Figs 2 and 3) . Thus, ICP-MS analysis of three SMP samples that were separated into membrane and supernatant fractions was conducted to determine iron content. The endogenous iron found in SMPs in mean nmol Fe/mg protein ± SD were: for membrane fractions, 3.89 ± 0.03 and for supernatant fractions, 0.90 ± 0.06. The mean nmol Fe/mg protein concentration for the supernatant is equivalent to a micromolar concentration under experimental conditions, and indicates that SMPs contained approximately 1 µM endogenous iron in solution. The majority of the endogenous iron (81%) was associated with the membrane fraction, most likely in the form of protein iron-sulfur centers or heme-iron.
Discussion
A growing body of evidence implicates mitochondrial dysfunction in the etiology of degenerative diseases that are associated with oxidative stress. Mitochondrial dysfunction has been observed in the protein agglomeration that leads to Alzheimer's disease, 20 in the dopaminergic neuron loss that occurs in familial and idiopathic Parkinson's disease 4, 21 and in a mouse model of hemochromatosis. 6 ROS generated from dysfunctional mitochondria may contribute to disease pathology. Under normal physiological conditions, antioxidant enzymes minimize cellular oxidations due to ROS. Our data indicate that exogenously added SOD and catalase significantly decrease HO
• production in SMPs both in the presence and absence of exogenous iron. When SOD and catalase were added simultaneously, the HO
• signal was decreased substantially. Our results support the notion that under normal metabolic conditions, little damage is expected from oxidants generated by the mitochondrial electron transport chain and Fenton chemistry. This observation is consistent with measurements of hydrogen peroxide and superoxide in rat tissues under non-oxidative stress conditions. 22 Thus, under normal conditions when the precursors to HO
• are generated at low levels, HO • levels will be minimized. However, during the persistent oxidative stress that occurs under pathological conditions, endogenous antioxidant defense systems may not provide sufficient protection. Our data imply that significant increases in HO
• levels will occur when electron transport is chemically inhibited or, by analogy, malfunctioning due to disease pathology or conformation abnormalities of electron transport proteins derived from genetic diseases. 23 The mitochondrial matrix sequesters a pool of chelatable iron that could exacerbate oxidative damage during increased ROS production. 13 Moreover, increased iron storage in mitochondria has been noted in central nervous system diseases as well as in aging animals. 9 Conditions of increased mitochondrial ROS generation and elevated iron set the stage for HO
• production via the Fenton reaction. With an estimated half-life of 10 -9 s, HO • reacts quickly and indiscriminately with substances that occur within a 93 Å radius. 24 The iron chelator, desferrioxamine, has been shown to decrease the cellular damage that is associated with iron-mediated oxidative injury. 25 Iron associated with desferrioxamine has a lower standard reduction potential (Eº′, -0.45 V, Fe -ADP) that favors its reduction by superoxide. When desferrioxamine was added to SMPs, a statistically significant decrease in HO
• production was observed. Consistent with previous work, 26 the desferrioxamine-dependent decrease in SMP-derived HO
• occurred in both the presence and absence of exogenous iron suggesting that SMPs contained an endogenous iron catalyst which was verified by ICP-MS. However, desferrioxamine did not completely remove DHBA production in SMPs. The DHBAs observed in reactions containing desferrioxamine (Fig. 2) can be explained by Fe 3+ binding to other ligands in the reaction mixture. One possible ligand is salicylate which has a log K value for Fe 3+ binding that is comparable to that of desferrioxamine (Table 1) . In order to trap hydroxyl radical efficiently, salicylate was at high concentrations in the reaction mixtures and was 100-750-fold higher than desferrioxamine. Salicylate is an effective chemical trap for hydroxyl radical, 15 and has been shown to provide protection against oxidative stress induced in paraquatexposed rats. 27 It is plausible that salicylate-bound iron functioned as a Fenton catalyst in our experimental system and as a specific target for HO
•
. Likewise, succinate could have participated in iron binding (Table  1 ). In addition, under conditions of oxidative stress, superoxide could induce the release of iron from mitochondrial membrane iron-sulfur centers in complexes I or II, as superoxide is known to cause the release of iron from iron-sulfur centers. 28 Subsequent binding of the released iron to organic ligands such as adenine nucleotides or succinate and other Krebs's cycle intermediates would form the Fenton catalyst in situ.
Although several reports have been published on the amounts, the location and the membrane-sidedness of superoxide and hydrogen peroxide production in mitochondria, 12, 22, 29, 30 sparse evidence documents HO
• formation. 26, 31 Here we report that significantly increased submitochondrial HO
• production occurs under conditions of oxidative stress caused by electron transport chain inhibition. Iron enhances HO
• production which is reversed by desferrioxamine, indicating that a redoxcycling iron catalyst is required. The effects of antioxidant enzyme additions, exogenous hydrogen peroxide, and HO
• scavenger studies strongly support the notion that HO
• was produced by a Fenton-type reaction. These results underline the importance of developing mitochondrialtargeted antioxidants in the prevention and treatment of diseases associated with mitochondrial dysfunction, oxidative stress and elevated iron. 32 In particular, therapeutic strategies that focus on modulating Fenton reaction conditions by removing catalytic iron, superoxide, and hydrogen peroxide could provide beneficial effects by diminishing the formation of HO 
